25 July 2017 - Leading neurosurgeon Kate Drummond has called on the Turnbull government to break the “bureaucratic mould” and ­approve reimbursement of a drug that prolongs the life of Australian brain cancer patients.

The debate on access to the drug was reignited after US senator John McCain was diagnosed with an aggressive brain tumour.

Australian regulators earlier this year knocked back a request to reimburse the drug, Gliolan, which has just been approved in the US. The drug, used across Britain and Europe as standard care, “lights up” the brain tumour, which helps the surgeon to ­remove as much of it as possible.

Read The Australian article